相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The drug-target residence time model: a 10-year retrospective
Robert A. Copeland
NATURE REVIEWS DRUG DISCOVERY (2016)
On the different experimental manifestations of two-state induced-fit' binding of drugs to their cellular targets
Georges Vauquelin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Design strategies to address kinetics of drug binding and residence time
Kevin P. Cusack et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
The Role of Binding Kinetics in GPCR Drug Discovery
David C. Swinney et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2015)
On the 'micro'-pharmacodynamic and pharmacokinetic mechanisms that contribute to long-lasting drug action
Georges Vauquelin
EXPERT OPINION ON DRUG DISCOVERY (2015)
PHARMACODYNAMICS Which trails are your drugs taking?
Rumin Zhang
NATURE CHEMICAL BIOLOGY (2015)
Prolonged and tunable residence time using reversible covalent kinase inhibitors
J. Michael Bradshaw et al.
NATURE CHEMICAL BIOLOGY (2015)
Target engagement and drug residence time can be observed in living cells with BRET
Matthew B. Robers et al.
NATURE COMMUNICATIONS (2015)
Pharmacokinetics and the drug-target residence time concept
Goran Dahl et al.
DRUG DISCOVERY TODAY (2013)
A comprehensive analysis of the influence of drug binding kinetics on drug action at molecular and systems levels
Ning Yin et al.
MOLECULAR BIOSYSTEMS (2013)
Target-drug interactions: first principles and their application to drug discovery
Sara Nunez et al.
DRUG DISCOVERY TODAY (2012)
Radioligand dissociation measurements: potential interference of rebinding and allosteric mechanisms and physiological relevance of the biological model systems
Georges Vauquelin et al.
EXPERT OPINION ON DRUG DISCOVERY (2012)
Determination of drug-receptor residence times by radioligand binding and functional assays: experimental strategies and physiological relevance
Georges Vauquelin
MEDCHEMCOMM (2012)
Comparative Biophysical Studies of Sartan Class Drug Molecules Losartan and Candesartan (CV-11974) with Membrane Bilayers
Charalambos Fotakis et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2011)
Influence of kinetics of drug binding on EGFR signaling: A comparative study of three EGFR signaling pathway models
Sneha Bairy et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2011)
Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action
Georges Vauquelin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Ligand binding assays at equilibrium: validation and interpretation
Edward C. Hulme et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Drug-target residence time: critical information for lead optimization
Hao Lu et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
Rebinding: or why drugs may act longer in vivo than expected from their in vitro target residence time
Georges Vauquelin
EXPERT OPINION ON DRUG DISCOVERY (2010)
The dynamics of drug-target interactions: drug-target residence time and its impact on efficacy and safety
Robert A. Copeland
EXPERT OPINION ON DRUG DISCOVERY (2010)
The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery
Dennis A. Smith et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Molecular mechanisms for the persistent bronchodilatory effect of the beta(2)-adrenoceptor agonist salmeterol
A. Szczuka et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Early integration of pharmacokinetic and dynamic reasoning is essential for optimal development of lead compounds: strategic considerations
Johan Gabrielsson et al.
DRUG DISCOVERY TODAY (2009)
Ligands, their receptors and ... plasma membranes
G. Vauquelin et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Residence time of receptor-ligand complexes and its effect on biological function
Peter J. Tummino et al.
BIOCHEMISTRY (2008)
Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research
Meindert Danhof et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Opinion - Drug-target residence time and its implications for lead optimization
Robert A. Copeland et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Slow antagonist dissociation and long-lasting in vivo receptor protection
Georges Vauquelin et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Diffusion delays and unstirred layer effects at monolayer cultures of chinese hamster ovary cells - Radioligand binding, confocal microscopy, and mathematical simulations
CE Spivak et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2006)
Effects of receptor clustering on ligand dissociation kinetics:: Theory and simulations
M Gopalakrishnan et al.
BIOPHYSICAL JOURNAL (2005)
Effects of the geometry of the immunological synapse on the delivery of effector molecules
D Coombs et al.
BIOPHYSICAL JOURNAL (2004)
Biochemical mechanisms of drug action: what does it take for success?
DC Swinney
NATURE REVIEWS DRUG DISCOVERY (2004)
Probing the mechanism of drug/lipid membrane interactions using Biacore
YN Abdiche et al.
ANALYTICAL BIOCHEMISTRY (2004)
Lipid rafts: bringing order to chaos
LJ Pike
JOURNAL OF LIPID RESEARCH (2003)
International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology
RR Neubig et al.
PHARMACOLOGICAL REVIEWS (2003)
A two-state receptor model for the interaction between angiotensin II type 1 receptors and non-peptide antagonists
G Vauquelin et al.
BIOCHEMICAL PHARMACOLOGY (2001)
分享论文
